8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
ResMed reports 6% revenue growth and raises quarterly dividend
Filed with the SEC on · Summarized by InvestorsBot
ResMed’s fiscal first-quarter revenue rose 6% year over year to $1.415 billion, while GAAP diluted EPS increased 23% to $2.92 and non-GAAP diluted EPS rose 14% to $2.91 for the quarter ended September 30, 2026. The company maintained fiscal 2027 guidance of 5%-7% core constant-currency revenue growth, reported revenue of $5.75-$5.85 billion and non-GAAP diluted EPS of $12.00-$12.25, and declared a $0.66-per-share dividend payable December 17, 2026; it also returned more than $1 billion through repurchases and dividends during the quarter.